Peijia Medical Limited (HKG:9996)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.975
-0.085 (-1.68%)
Aug 21, 2026, 4:08 PM HKT

Peijia Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-203.29-226.58-392.53-407.81-574.22
Depreciation & Amortization
65.2356.7340.233.9826.33
Other Amortization
2.632.332.612.031.15
Loss (Gain) From Sale of Assets
-0.050.370.220.030.22
Loss (Gain) From Sale of Investments
-9.4614.98-4.05-0.58-0.68
Loss (Gain) on Equity Investments
---0.17-
Stock-Based Compensation
11.6510.1228.2527.9530.93
Other Operating Activities
3.8-22.1-31.29-100.4765.89
Change in Inventory
-0.9824.66-44.47-63.06-40.82
Change in Accounts Payable
61.7594.7-258.97193.5379.36
Change in Unearned Revenue
---0.35-1.91
Change in Other Net Operating Assets
47.8439.6229.11-62.32-22.62
Operating Cash Flow
-20.89-5.18-630.91-376.2-436.37
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-231.59-249.14-175.62-130.41-69.74
Sale of Property, Plant & Equipment
0.4-0.250.060.01
Sale (Purchase) of Intangibles
-72.8-30.97-140.56-71.93-123.3
Investment in Securities
26.51100.86-42.98-244.08-224.11
Other Investing Activities
-40.0938.8720.21-16.92-7.62
Investing Cash Flow
-317.57-140.38-338.7-463.28-424.76

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
27053146.48126.69-
Total Debt Issued
27053146.48126.69-
Long-Term Debt Repaid
-92.36-25.54-59.41-3.37-3.16
Total Debt Repaid
-92.36-25.54-59.41-3.37-3.16
Net Debt Issued (Repaid)
177.6427.4687.07123.32-3.16
Issuance of Common Stock
8.95-4.052.11813.93
Repurchase of Common Stock
--26.69--5.18-64.72
Other Financing Activities
25.619.6-6.18-2.81-4.07
Financing Cash Flow
212.210.3884.95117.44741.98

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.746.1510.7795.59-42.91
Net Cash Flow
-130-129.03-873.9-626.45-162.05

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-252.48-254.32-806.54-506.61-506.11
Free Cash Flow Growth
-----
Free Cash Flow Margin
-35.42%-41.32%-182.84%-201.97%-370.68%
Free Cash Flow Per Share
-0.38-0.38-1.19-0.75-0.77
Levered Free Cash Flow
-407.32-124.36-861.09-73.89-250.08
Unlevered Free Cash Flow
-399.98-121.4-860.98-72.45-249.96

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
10.348.96.183.120.19
Cash Income Tax Paid
8.237.923.449.57-
Change in Working Capital
108.61158.97-274.3268.514.01